Truist Maintains AMERISAFE at Hold, Cuts Price Target to $25
Truist Securities maintained its Hold rating on AMERISAFE and lowered its price target to $25 from $27.
Truist Securities maintained its Hold rating on AMERISAFE and lowered its price target to $25 from $27.